Humana down after CMS posts Medicare Part C and D performance data

Humana (HUM) shares are weaker in premarket trading after the U.S. Medicare program released final quality ratings for private Medicare Advantage plans, confirming a previously warned about cut for the “Star ratings” of the health insurer. The posting confirms that one of Humana’s largest contracts for Medicare Advantage membership dropped to a lower rating on the government’s star system, jeopardizing bonus payments from the U.S. health program for the elderly and disabled due in 2026. Other publicly traded healthcare insurers that may be impacted by the Medicare plan ratings include CVS Health (CVS), Centene (CNC), Cigna (CI), Elevance Health (ELV), Molina Healthcare (MOH) and UnitedHealth (UNH). In early Friday morning trading, shares of Humana are down $9.04, or nearly 4%, to $242.40.